Guess which ASX medical tech share soared 37% at one point today

We take a look at why this medical technology company soared ahead today.

Key points
  • This one medical technology company soared 37% today before pulling back slightly  
  • The company's share price finished the day nearly 26% in the green 
  • The company secured a major investment from a global x-ray manufacturer 

The Micro-X Ltd (ASX: MX1) share price exploded today on news of a $15 million investment.

Micro-X shares surged 37% from 13.5 cents to 18.5 cents before retreating. The company's shares finished the day up 26%.

Let's take a look at what this ASX medical tech share reported.

Person pointing at an increasing blue graph which represents a rising share price.

Image source: Getty Images

New strategic partnership

Micro-X has formed a strategic partnership with Varex Imaging Corporation (NASDAQ: VREX). Varex is said to be the biggest independent manufacturer of x-ray technology components in the world.

Varex will pay Micro-X US$5 million (about A$7.5 million) for a global exclusive licence to use Micro-X's NEX technology. Under the deal, Varex will be able to design, make and sell multi-beam x-ray tubes using this technology.

Further, Varex will take a 9.9% stake in Micro-X via a share placement of 50,709,000 shares at 14.7 cents per share. This investment is valued at nearly $7.5 million. In total, this would take Varex's investment in Micro-X to about $15 million.

Commenting on the news, Micro-X managing director Peter Rowland said:

This long-term investment will continue to promote Micro-X on the world stage, as a leader in innovative products and technology that is designed to make lives better.

This collaboration contributes hugely to our future growth and allows us to continue to focus on future medical and security imaging applications for our proprietary NEX Technology

Micro-X is holding an investor call at 9am on Tuesday to discuss this news.

Micro-X share price snapshot

The Micro-X share price has slid 42% in the past year, while it has fallen 33% year to date.

For perspective, the S&P/ASX 200 Health Care Index (ASX: XHJ) has fallen nearly 14% in a year.

Micro-X has a market capitalisation of about $78 million based on the current share price.

Motley Fool contributor Monica O'Shea has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A female scientist in a laboratory setting using a tablet to review data, with a male scientist working in the background.
Healthcare Shares

Down 44%: Will you regret not buying Pro Medicus shares?

The shares have fallen hard, but the business itself continues to grow at an impressive rate.

Read more »

Two colleagues looking at a graph and comparing share prices.
Healthcare Shares

CSL shares: Buy, hold, or sell?

The shares have recovered sharply, so I wanted to see whether the valuation still stacks up.

Read more »

Two colleagues looking at a graph and comparing share prices.
Healthcare Shares

Telix vs Clinuvel Pharmaceuticals: Which ASX healthcare share deserves your next $1,000 of investment capital?

We compare Telix and Clinuvel Pharmaceuticals on valuation, dividends, and momentum—which ASX healthcare stock looks more compelling now?

Read more »

Numerous Australian dollar notes laid out.
Healthcare Shares

I'd buy 6,462 shares of this ASX stock to aim for $200 a month of passive income

This business can provide very healthy dividends.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

UBS thinks Telix Pharmaceuticals shares will go how high?

Good news out of the US has led to a share price target upgrade.

Read more »

Scientist taking down notes from a tablet, with two other scientists working in the background.
Healthcare Shares

Healius vs Australian Clinical Labs: Which ASX pathology share wins?

Healius and Australian Clinical Labs are both top pathology providers, but one stands out for profits, dividends, and recent momentum.

Read more »

Doctor looks at a graph on a tablet.
Healthcare Shares

Ramsay Health Care vs Sonic Healthcare: Which healthcare stock is better value?

Which offers better value — Ramsay Health Care or Sonic Healthcare? I compare their fundamentals, dividends, momentum and reveal my…

Read more »

A doctor looks unsure.
Healthcare Shares

CSL shares jump 93%: Is the ASX biotech stock a buy, sell or hold for October?

Can the CSL share price rebound keep going?

Read more »